Jubilant Pharmova shares jumped more than 24% this week after the company after its subsidiary Jubilant HollisterStier received the ‘VAI’ tag from the United States Food and Drugs Administration (USFDA).
On Tuesday, Jubilant Pharmova announced that the US drug regulatory agency had classified Jubilant HollisterStier’s Washington plant as “Voluntary Action iIndicated.”
In the exchange filing, the company shared, “US FDA had audited JHS’s contract manufacturing facility located at Spokane, Washington (USA) from May 28,2024 to June 6, 2024, it has determined the inspection classification of the facility as ‘Voluntary Action Indicated.”
Stock Performance on Friday
– Open: ₹1,050.00
– High: ₹1,227.00
– Low: ₹1,032.20